BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 293 | Download: 738
 |
Received |
|
2023-03-24 10:03 |
 |
Peer-Review Started |
|
2023-03-24 10:06 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-05-13 23:51 |
 |
Revised |
|
2023-05-25 18:58 |
 |
Second Decision |
|
2023-06-21 02:58 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-06-21 08:58 |
 |
Articles in Press |
|
2023-06-21 08:58 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-07-04 09:21 |
 |
Publish the Manuscript Online |
|
2023-07-13 08:46 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
|
Manuscript Source |
Invited Manuscript |
All Author List |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov and Vladimir Ivashkin |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Roman Maslennikov, MD, PhD, Academic Editor, Assistant Professor, Doctor, Doctor, Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya str., 1, bld. 1, Moscow 119435, Russia. mmmm00@yandex.ru |
Key Words |
Cirrhosis; Muscle; Fragility; Liver; Microbiota; Microbiome |
Core Tip |
Sarcopenia is common in patients with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this disorder has not been fully elucidated, a disordered gut-muscle axis probably plays an important role. Drugs that target the gut microbiota positively affect most links of the compromised gut-muscle axis in patients with cirrhosis. However, they have not yet been investigated in randomized controlled trials specifically for the treatment and prevention of sarcopenia in patients with cirrhosis. |
Publish Date |
2023-07-13 08:46 |
Citation |
Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251 |
URL |
https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v29.i27.4236 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345